首页> 外文期刊>Journal of the American Chemical Society >High-Throughput 3D Cell Invasion Chip Enables Accurate Cancer Metastatic Assays
【24h】

High-Throughput 3D Cell Invasion Chip Enables Accurate Cancer Metastatic Assays

机译:高通量3D细胞浸润芯片可实现准确的癌症转移测定

获取原文
获取原文并翻译 | 示例
       

摘要

Chemotaxis is the phenomenon by which the migration and invasion of cells is directed in response to an extracellular chemical gradient. Chemotaxis of tumor cells and tumor-associated inflammatory and stromal cells is mediated by chemokines, chemokine receptors, growth factors, and growth factor receptors. Current techniques used to study chemotactic driven cell invasion and metastasis utilize two-dimensional migration assays involving imaging and analyzing tumor cells on glass slides or plastic surfaces, which requires large numbers of cells and often lacks real-time monitoring of vertical cell movement and systematically controlled chemotactic gradients, leading to contradictory results compared to those from clinical investigations and animal models. We addressed such challenges by developing a high-throughput microdevice with 4000 ultraminiaturized wells to monitor real-time, three-dimensional cell invasion over a wide range of cell densities and also screen drags that inhibit cell invasion and potentially prevent metastatic malignancy. Additionally, this microdevice generates opposing gradients for two types of cells on the same chip, which builds a controlled system with sequentially changing components to study environmental effects from basal and immune cells.
机译:趋化性是响应细胞外化学梯度而指导细胞迁​​移和侵袭的现象。趋化因子,趋化因子受体,生长因子和生长因子受体介导肿瘤细胞和与肿瘤相关的炎性和基质细胞的趋化性。用于研究趋化性驱动的细胞侵袭和转移的当前技术利用二维迁移测定法,涉及对载玻片或塑料表面上的肿瘤细胞进行成像和分析,这需要大量细胞,并且通常缺乏对垂直细胞运动的实时监控和系统控制趋化梯度,导致与临床研究和动物模型的结果相矛盾。我们通过开发具有4000个超小型化孔的高通量微型设备来监控各种细胞密度的实时三维细胞侵袭,并筛选出抑制细胞侵袭并潜在预防转移性恶性肿瘤的药物,从而解决了这些挑战。此外,该微型设备在同一芯片上为两种类型的细胞生成相反的梯度,从而构建了一个受控系统,该系统具有依次变化的组件,以研究基础细胞和免疫细胞对环境的影响。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2014年第43期|15257-15262|共6页
  • 作者单位

    Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States,Department of Cell and Developmental Biology, Weill Medical College of Cornell University, New York, New York 10065, United States;

    Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States,Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China;

    Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States,Department of Cell and Developmental Biology, Weill Medical College of Cornell University, New York, New York 10065, United States,Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:11:14

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号